On the sad passing of Eye News’ first editor and long-term contributor JF (Barry) Cullen, his friend Hector Chawla takes a look at the life and career of this effervescent character and giant of the ophthalmology world. Barry Cullen was...
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate and the rapid scaling of its manufacturing capacity with the goal of providing global supply of more than one billion doses.
As part of this year’s World Glaucoma Week, Glaucoma UK is encouraging people to make eye health part of their conversations – whether by booking an eye test, raising awareness, or learning more about glaucoma. World Glaucoma Week (WGW) is...
New dates. New location. Same unmissable experience. SightCare is delighted to announce that SightCare LIVE 2026 – the flagship conference, awards and exhibition – will take place on Sunday 26 and Monday 27 April 2026 at an exciting new venue:...
A refreshing, systematic approach to eye pain, arguably one of the most commonly presenting symptoms and one that can be fraught with diagnostic challenges and management dilemmas for the busy clinician. There is a scarcity of books covering this particular...
The authors present a case of closure of a full thickness macular hole in a patient with Behçet’s disease, without surgery. The 23-year-old male they describe presented with a history of recurrent oral aphthous ulcers and a genital ulcer. Ocular...
Hanson Medical, a leading supplier of medical technology, has secured an exclusive agreement to become the sole distributor of Norlase's next-generation ophthalmic laser solutions. Hanson Medical will be offering all three of Norlase’s lasers to UK and Republic of Ireland...
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...
This is a masked study of 33 patients who had been taking a prostaglandin analogue in one eye only for at least a year, to look for signs of prostaglandin-associated periorbitopathy (PAP). The investigators devised a new grading system to...